What Is Reprocessing Validation?

Reprocessing validation is the scientific process of confirming that the cleaning, disinfection, and/or sterilization instructions provided for a reusable medical device actually work — consistently, in the hands of the intended user, using the equipment and consumables specified in the Instructions for Use (IFU).

It typically covers three linked but distinct validation activities:

• Cleaning validation – demonstrating that manual or automated cleaning steps remove soil, blood, tissue, and bioburden to an acceptable residual level.
• Disinfection validation – confirming that high-level or intermediate-level disinfection achieves the required log reduction in microorganisms.
• Sterilization validation – proving that a chosen sterilization modality (steam, ethylene oxide, hydrogen peroxide, etc.) reliably achieves a validated sterility assurance level (SAL).

Each stage must be validated using worst-case conditions: the dirtiest realistic soil, the longest allowable time-to-reprocessing, the most challenging device geometry (lumens, hinges, mated surfaces), and the least-experienced likely user.

Why Reprocessing Validation Matters

Inadequately validated reprocessing instructions have been directly linked to healthcare-associated infections (HAIs), including well-publicized outbreaks involving duodenoscopes and other complex reusable instruments. For regulators, reprocessing has become one of the most frequently cited deficiency areas in premarket submissions — alongside biocompatibility and cybersecurity.

For manufacturers, the stakes are twofold:

1. Patient safety — a device that looks clean but retains bioburden or biofilm can transmit infection.
2. Regulatory clearance — under 21 CFR 801.5(g), manufacturers must provide adequate directions for use, and FDA interprets this as including scientifically validated reprocessing instructions. Submissions with unvalidated or vaguely worded reprocessing sections are a common cause of Additional Information (AI) requests and review delays.

Key Standards and Guidance Documents

A reprocessing validation program should be built around the current recognized standards, not internal assumptions. The core framework includes:

• FDA Guidance – “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” (issued 2015, amended 2017) — the foundational U.S. guidance describing the scientific evidence FDA expects and the labeling content required in premarket submissions.
• ISO 17664-1 – reprocessing validation requirements for critical and semi-critical reusable devices.
• ISO 17664-2 – requirements for non-critical devices.
• ANSI/AAMI ST98 – cleaning validation of healthcare products, including test soil selection and acceptance criteria.
• AAMI TIR12 – guidance on designing, testing, and labeling reusable medical devices for reprocessing.
• AAMI TIR30 – a compendium of processes, materials, and test methods for cleaning validation.
• ANSI/AAMI ST81 – FDA-recommended reference for developing reprocessing instructions.
• ISO 15883 series – performance and validation requirements for automated washer-disinfectors.
• ASTM F3208 – guide for selecting test soils used in cleaning validation studies.

Note that not every section of every standard is FDA-recognized without qualification — some elements of ISO 17664-1, for example, fall outside FDA’s scope of recognition where they diverge from the agency’s own guidance. Manufacturers should always cross-check the current FDA Recognized Consensus Standards Database before finalizing a validation protocol.

The Reprocessing Validation Process, Step by Step

1. Device and Risk Assessment

Classify the device (critical, semi-critical, or non-critical) based on its intended contact with tissue, mucous membranes, or sterile body sites. This classification drives whether sterilization, high-level disinfection, or lower-level disinfection is required.

2. Design for Cleanability Review

Reprocessing validation starts at the design stage, not the test bench. Features like long narrow lumens, hinges, mated surfaces, and porous materials all make cleaning harder and must be engineered with reprocessing in mind.

3. Worst-Case Soil and Contamination Modeling

Select or formulate an artificial test soil that represents the most challenging realistic clinical contamination, per AAMI ST98 and ASTM F3208 guidance.

4. Cleaning Efficacy Testing

Simulate the labeled cleaning method (manual, automated, or both) and measure residual protein, hemoglobin, total organic carbon, or bioburden against defined acceptance criteria.

5. Disinfection or Sterilization Validation

Challenge the device with a defined microbial load and confirm the labeled process achieves the required log reduction or sterility assurance level, accounting for the device’s most difficult-to-reach surfaces.

6. Simulated-Use and Human Factors Testing

Confirm that a representative user, following only the written IFU, can actually perform the reprocessing steps correctly — this is where many otherwise “valid” protocols fail in practice.

7. Documentation and Labeling

Translate the validated protocol into clear, step-by-step IFU language, and compile the supporting data package for inclusion in the premarket submission (510(k), PMA, De Novo, or IDE).

Common Pitfalls in Reprocessing Validation

• Using a test soil that doesn’t represent worst-case clinical contamination.
• Validating only the “ideal” reprocessing pathway rather than the one an average technician will realistically follow.
• Overlooking difficult-to-access features such as lumens, valves, or channel intersections.
• Failing to align IFU language with what was actually tested (a common source of FDA Additional Information requests).
• Treating reprocessing validation as a one-time event rather than revisiting it after design changes, new accessories, or updated reprocessing equipment.

Building an Audit-Ready Reprocessing Validation Program

A defensible program ties together design controls, risk management (per ISO 14971), and reprocessing validation data into a single traceable package. Best practice includes:

• Establishing reprocessing requirements early in the design history file, not retroactively.
• Using accredited third-party labs for cleaning, disinfection, and sterilization testing where in-house capability is limited.
• Keeping validation protocols aligned with the current editions of FDA guidance and AAMI/ISO standards, since these are periodically updated.
• Maintaining full traceability between test data, risk assessments, and final IFU wording.

Frequently Asked Questions

Does every reusable medical device need reprocessing validation? Yes. Any device labeled for reuse between patients must have scientifically validated reprocessing instructions, regardless of its regulatory classification or 510(k) status.

How long does reprocessing validation testing take? Timelines vary by device complexity, but a full cleaning, disinfection, and sterilization validation package commonly takes several months when accounting for protocol development, testing, and data analysis.

Is reprocessing validation different for single-use devices reprocessed by third parties? Yes. Third-party and hospital reprocessing of “single-use” devices is regulated separately and historically has faced its own, sometimes more stringent, validation expectations.

Final Thoughts

Reprocessing validation isn’t a paperwork exercise — it’s the evidence base that stands between a reusable device and a preventable infection. Building it into the design process early, grounding it in current FDA and AAMI/ISO standards, and testing under genuinely worst-case conditions is what separates a submission that clears review from one that stalls on Additional Information requests.